|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
2
|
|
pubmed:dateCreated |
2004-3-12
|
|
pubmed:abstractText |
Liver biopsy has been largely replaced by less invasive measurements applied to mathematical models in defining the prognosis of patients with primary biliary cirrhosis (PBC). The need for liver biopsy in the diagnosis of patients with positive antimitochondrial antibodies (AMAs) in the setting of biochemical cholestasis remains uncertain. This study was undertaken to determine which variables indicate the need for liver biopsy in patients with positive AMA and suspected PBC.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Mar
|
|
pubmed:issn |
1542-3565
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
1
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
89-95
|
|
pubmed:dateRevised |
2006-9-18
|
|
pubmed:meshHeading |
pubmed-meshheading:15017500-Alkaline Phosphatase,
pubmed-meshheading:15017500-Antibodies,
pubmed-meshheading:15017500-Biopsy,
pubmed-meshheading:15017500-Cholestasis,
pubmed-meshheading:15017500-Female,
pubmed-meshheading:15017500-Humans,
pubmed-meshheading:15017500-Liver,
pubmed-meshheading:15017500-Liver Cirrhosis, Biliary,
pubmed-meshheading:15017500-Male,
pubmed-meshheading:15017500-Middle Aged,
pubmed-meshheading:15017500-Mitochondria, Liver,
pubmed-meshheading:15017500-ROC Curve,
pubmed-meshheading:15017500-Sensitivity and Specificity
|
|
pubmed:year |
2003
|
|
pubmed:articleTitle |
When is liver biopsy needed in the diagnosis of primary biliary cirrhosis?
|
|
pubmed:affiliation |
Division of Gastroenterology and Hepatology, Mayo Clinic and Foundation, Rochester, Minnesota 55905, USA.
|
|
pubmed:publicationType |
Journal Article
|
